
Page#1
WESTROCK COMPANY
CONSOLIDATED STATEMENTS OF OPERATIONS
Year Ended September 30,
(In millions, except per share data) 2018 2017 2016
Net sales $ 16,285.1 $ 14,859.7 $ 14,171.8
Cost of goods sold 12,891.2 12,119.5 11,413.2
Selling, general and administrative, excluding intangible
amortization 1,493.3 1,399.6 1,379.4
Selling, general and administrative intangible amortization 296.6 229.6 211.8
Multiemployer pension withdrawals 184.2  
Pension risk transfer expense   370.7
Pension lump sum settlement  32.6 
Land and Development impairments 31.9 46.7 
Restructuring and other costs 105.4 196.7 366.4
Operating profit 1,282.5 835.0 430.3
Interest expense, net (293.8) (222.5) (212.5)
(Loss) gain on extinguishment of debt (0.1) 1.8 2.7
Other income, net 12.7 11.5 14.4
Equity in income of unconsolidated entities 33.5 39.0 9.7
Gain on sale of HH&B  192.8 
Income from continuing operations before income taxes 1,034.8 857.6 244.6
Income tax benefit (expense) 874.5 (159.0) (89.8)
Income from continuing operations 1,909.3 698.6 154.8
Loss from discontinued operations (net of income tax
benefit of $0, $0 and $32.3)   (544.7)
Consolidated net income (loss) 1,909.3 698.6 (389.9)
Less: Net (income) loss attributable to noncontrolling
interests (3.2) 9.6 (6.4)
Net income (loss) attributable to common stockholders $ 1,906.1 $ 708.2 $ (396.3)
Basic earnings per share from continuing operations $ 7.46 $ 2.81 $ 0.60
Basic loss per share from discontinued operations   (2.16)
Basic earnings (loss) per share attributable to common
stockholders $ 7.46 $ 2.81 $ (1.56)
Diluted earnings per share from continuing operations $ 7.34 $ 2.77 $ 0.59
Diluted loss per share from discontinued operations   (2.13)
Diluted earnings (loss) per share attributable to common
stockholders $ 7.34 $ 2.77 $ (1.54)
Cash dividends paid per share $ 1.72 $ 1.60 $ 1.50
See Accompanying Notes
59
Page#2
WESTROCK COMPANY
CONSOLIDATED BALANCE SHEETS
September 30,
(In millions, except per share data) 2018 2017
ASSETS
Current Assets:
Cash and cash equivalents $ 636.8 $ 298.1
Restricted cash  5.9
Accounts receivable (net of allowances of $49.7 and $45.8) 2,010.7 1,886.8
Inventories 1,829.6 1,797.3
Other current assets 248.5 329.2
Assets held for sale 59.5 173.6
Total current assets 4,785.1 4,490.9
Property, plant and equipment, net 9,082.5 9,118.3
Goodwill 5,577.6 5,528.3
Intangibles, net 3,122.0 3,329.3
Restricted assets held by special purpose entities 1,281.0 1,287.4
Prepaid pension asset 420.0 368.0
Other assets 1,092.3 966.8
Total Assets $ 25,360.5 $ 25,089.0
LIABILITIES AND EQUITY
Current liabilities:
Current portion of debt $ 740.7 $ 608.7
Accounts payable 1,716.8 1,492.1
Accrued compensation and benefits 399.3 416.7
Other current liabilities 476.5 492.3
Total current liabilities 3,333.3 3,009.8
Long-term debt due after one year 5,674.5 5,946.1
Pension liabilities, net of current portion 261.3 279.4
Postretirement benefit liabilities, net of current portion 134.8 153.4
Non-recourse liabilities held by special purpose entities 1,153.7 1,161.9
Deferred income taxes 2,321.5 3,410.2
Other long-term liabilities 994.8 737.4
Commitments and contingencies (Notes 14 and 17)
Redeemable noncontrolling interests 4.2 4.7
Equity:
Preferred stock, $0.01 par value; 30.0 million shares authorized; no
shares outstanding  
Common stock, $0.01 par value; 600.0 million shares authorized;
253.5 million and 254.5 million shares outstanding at September
30, 2018 and September 30, 2017, respectively 2.5 2.5
Capital in excess of par value 10,588.9 10,624.9
Retained earnings 1,573.3 172.4
Accumulated other comprehensive loss (695.3) (457.3)
Total stockholders equity 11,469.4 10,342.5
Noncontrolling interests 13.0 43.6
Total equity 11,482.4 10,386.1
Total Liabilities and Equity $ 25,360.5 $ 25,089.0
See Accompanying Notes
61
Page#3
WESTROCK COMPANY
CONSOLIDATED STATEMENTS OF CASH FLOWS
Year Ended September 30,
(In millions) 2018 2017 2016
Operating activities:
Consolidated net income (loss) $ 1,909.3 $ 698.6 $ (389.9)
Adjustments to reconcile consolidated net income to net cash
provided by operating activities:
Depreciation, depletion and amortization 1,252.2 1,112.1 1,141.9
Cost of real estate sold 121.2 207.9 87.7
Deferred income tax benefit (1,069.4) (20.4) (160.9)
Share-based compensation expense 66.8 58.0 75.7
Pension and other postretirement funding (more) than expense
(income) (96.8) (51.0) 275.6
Multiemployer pension withdrawals 184.2  
Gain on sale of HH&B  (192.8) 
Land and Development impairments 31.9 46.7 
Other impairment adjustments 13.5 56.8 200.8
Impairment of Specialty Chemicals goodwill and intangibles   579.4
Other (85.5) (92.2) (87.1)
Change in operating assets and liabilities, net of acquisitions and
divestitures:
Accounts receivable (143.4) (97.9) 36.6
Inventories (72.1) (48.2) 50.6
Other assets (22.6) (33.7) (92.7)
Accounts payable 180.3 302.2 (197.1)
Income taxes 130.6 (67.1) 73.2
Accrued liabilities and other 20.7 21.5 94.6
Net cash provided by operating activities 2,420.9 1,900.5 1,688.4
Investing activities:
Capital expenditures (999.9) (778.6) (796.7)
Cash paid for purchase of businesses, net of cash acquired (239.9) (1,588.5) (376.4)
Debt purchased in connection with an acquisition   (36.5)
Investment in unconsolidated entities (114.3) (2.5) (179.9)
Proceeds from sale of HH&B  1,005.9 
Proceeds from sale of property, plant and equipment 23.3 52.6 31.2
Other 31.9 25.3 6.9
Net cash used for investing activities (1,298.9) (1,285.8) (1,351.4)
Financing activities:
Proceeds from issuance of notes 1,197.3 998.4 
(Repayments) additions to revolving credit facilities (115.5) 421.8 125.5
Additions to debt 855.2 742.6 1,511.8
Repayments of debt (2,032.9) (2,331.9) (1,073.3)
Other financing (repayments) additions (24.2) 23.9 53.3
Specialty Chemicals spin-off of net cash and trust funding   (105.0)
Issuances of common stock, net of related minimum tax withholdings 26.6 35.8 11.8
Purchases of common stock (195.1) (93.0) (335.3)
Cash dividends paid to stockholders (440.9) (403.2) (380.7)
Cash distributions paid to noncontrolling interests (33.3) (47.0) (33.5)
Other 7.7 (2.8) (5.6)
Net cash used for financing activities (755.1) (655.4) (231.0)
Effect of exchange rate changes on cash and cash equivalents (28.2) (2.1) 6.6
Increase (decrease) in cash and cash equivalents 338.7 (42.8) 112.6
Cash and cash equivalents at beginning of period (2016 includes
$20.5 from discontinued operations) 298.1 340.9 228.3
Cash and cash equivalents at end of period $ 636.8 $ 298.1 $ 340.9
64